US Stocks
/
Syndax Pharmaceuticals, Inc. Share Price

Syndax Pharmaceuticals, Inc. Share Price

NASDAQ: SNDX | Small Cap
$16.89
-$0.18 (-1.03%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Syndax Pharmaceuticals, Inc. Stock Performance

Open
$16.68
Prev. Close
$17.07
Circuit Range
N/A
Day Range
$16.41 - $17.27
Year Range
$13.00 - $25.58
Volume
99,820
Average Traded
$16.93

Syndax Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Syndax Pharmaceuticals, Inc.'s share price is $16.89. The stock opened at $16.68, compared to its previous close of $17.07. During today's trading session, Syndax Pharmaceuticals, Inc.'s share price traded between $16.41 and $17.27, with an average price of $16.84. Over the past 52 weeks, the stock has recorded a high of $25.58 and a low of $13.00. In terms of performance, Syndax Pharmaceuticals, Inc.'s share price has declined by 21.39% over the last six months and is up 23.28% on a year-on-year basis.

Syndax Pharmaceuticals, Inc. Share Price Chart

$16.41$17.27
L
Show Current Price
H

Syndax Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.46B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.47
Revenue (TTM)
$172.35B
Return On Equity (TTM)
-1462.12%
Profit Margin
-165.60%
Debt to Equity
39.00
Quarterly Earnings Growth YoY
18.71%

Syndax Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$45.87$68.73$64.86$72.79
Net Profit-$60.72-$68.01-$42.67-$49.36
Net Profit Margin-132.37%-98.95%-65.79%-67.81%
Income ChangeN/A-12.01%37.26%-15.68%

Syndax Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$23.68$172.35
Net Profit-$149.34-$209.36-$318.76-$285.42
Net Profit MarginN/AN/A-1346.11%-165.60%
Income ChangeN/A-40.19%-52.25%10.46%

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Syndax Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$18.46
$16.89
-10.40%
Sep 2026
$19.58
$18.86
-6.43%
Aug 2026
$19.09
$20.15
+5.86%
Jul 2026
$22.06
$19.04
-12.84%
Jun 2026
$19.30
$21.84
+11.49%
May 2026
$20.98
$19.59
-8.82%
Apr 2026
$23.85
$21.48
-8.07%
Mar 2026
$21.63
$23.37
+7.60%
Feb 2026
$20.45
$21.72
+6.84%
Jan 2026
$21.18
$20.33
-3.28%
Dec 2025
$19.71
$21.02
+5.95%
Nov 2025
$13.67
$19.84
+44.82%

SNDX Share Price FAQs

What is Syndax Pharmaceuticals, Inc. share price today?

chevron-up
Syndax Pharmaceuticals, Inc. share price today is $16.89 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Syndax Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Syndax Pharmaceuticals, Inc. stock is $25.58, while the 52 week low is $13.00 as of 9 Oct '26.

What is SNDX's market capitalisation today?

chevron-up
SNDX market capitalisation is $1.46B as of October 9, 2026, at 4:48 pm IST.

What is SNDX's net income for the last quarter?

chevron-up
SNDX's net income for the last quarter is -49.36B USD.

What is the 5 year returns of SNDX?

chevron-up
The 5 year returns of SNDX is -13.16% as on 9 Oct '26.

What is the high & low stock price of SNDX today?

chevron-up
SNDX stock price hit a high of $17.27 and low of $16.41 as of 9 Oct '26.

Can I buy SNDX shares in India?

chevron-up
Yes. You can buy SNDX in India by opening an international trading account.